Guerbet lands expanded FDA clearance for Dotarem
French contrast developer Guerbet said the U.S. Food and Drug Administration...Read more on AuntMinnie.comRelated Reading:
EMA confirms clampdown on linear gadolinium agents
Guerbet phases out 2 contrast agents
Guerbet invests in French medical technology fund
FDA finds no health effects from gadolinium retention
Guerbet sees 7% growth in Q1 revenue
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news